Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

Blood (2020) 136 (12): 1442–1455.

https://doi.org/10.1182/blood.2020005957

Published: 2020

Includes: Supplemental data

Journal Articles

T-Cell Derived Interferon Gamma Directly Targets Intestinal Epithelium to Induce Stem Cell Apoptosis in GI Gvhd

Shuichiro Takashima, MD PhD, Maria L. Martin, PhD, Suze A. Jansen, Ya-Yuan Fu, PhD, Anastasiya Egorova, Chen Liu, MD PhD, Richard Kolesnick, MD, Caroline A. Lindemans, MD, Alan M. Hanash, MD PhD

Blood (2019) 134 (Supplement_1): 585.

https://doi.org/10.1182/blood-2019-130811

Published: 2019

Journal Articles

Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair

Kidist Ashami, BA, Sena Kim, PhD, Ravi Vij, MBBS, Julie K. Ritchey, Srikanth Santhanam, PhD, Sora Lim, MS, Sarah Peterson, Matthew Ciorba, MD, John F. DiPersio, MD PhD, Jaebok Choi, PhD

Blood (2019) 134 (Supplement_1): 4420.

https://doi.org/10.1182/blood-2019-126167

Published: 2019

Journal Articles

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Qingxiao Song, MD, Xiaoning Wang, MD, Paul J Martin, MD, Yuanzhong Chen, MD PhD, Defu Zeng, MD

Blood (2018) 132 (Supplement 1): 2030.

https://doi.org/10.1182/blood-2018-99-119966

Published: 2018

Journal Articles

Inhibition of HIF Prolyl Hydroxylases Mitigate Gut Graft-Versus-Host Disease

Rena Feinman, PhD, Iriana Colorado, MSc, Keyi Wang, MSc, Eugenia Dziopa, MSc, Michael A Flynn, MSc, Kevin Peters, MD, Andrew L. Pecora, MD, Robert Korngold, PhD

Blood (2016) 128 (22): 3349.

https://doi.org/10.1182/blood.V128.22.3349.3349

Published: 2016

Journal Articles

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

Daisuke Koyama, MD, Makoto Murata, MD PhD, Ryo Hanajiri, MD PhD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Jakrawadee Julamanee, MD, Erina Takagi, MD, Kotaro Miyao, MD, Reona Sakemura, MD, Tatsunori Goto, MD, Aika Seto, MD, Yukiyasu Ozawa, MD PhD, Koichi Miyamura, MD PhD, Seitaro Terakura, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3426.

https://doi.org/10.1182/blood.V128.22.3426.3426

Published: 2016

Journal Articles

High Mobility Group A1 Chromatin Remodeling Protein Regulates Self-Renewal, Niche Formation, and Regenerative Function in Adult Stem Cells through Wnt/β-Catenin Signaling

Linda Resar, MD, Lingling Xian, MD PhD, Tait Huso, Amy Belton, PhDBSc, Leslie Cope, PhDBSc, David Huso, DVM, PhD

Blood (2016) 128 (22): 2647.

https://doi.org/10.1182/blood.V128.22.2647.2647

Published: 2016

Journal Articles

Intestinal Epithelial HIF-2 Is Protective in Gut Graft-Versus-Host-Disease

Rena Feinman, PhD, Iriana Colorado, MSc, Keyi Wang, BSc, Eugenia Dziopa, MSc, Leah Dziopa, MSc, Zheng Yang, MSc, Robert Korngold, PhD

Blood (2015) 126 (23): 1865.

https://doi.org/10.1182/blood.V126.23.1865.1865

Published: 2015

Journal Articles

R-spondin1 Promotes Paneth Cell Growth, Maintains Intestinal Microbial Ecology, and Ameliorates GvHD

Eiko Hayase, MD, Daigo Hashimoto, MD PhD, Kiminori Nakamura, PhD, Yoshitoshi Ogura, PhD, Tetsuya Hayashi, MD PhD, Ken Kurokawa, PhD, Tokiyoshi Ayabe, MD PhD, Takanori Teshima, MD PhD

Blood (2015) 126 (23): 230.

https://doi.org/10.1182/blood.V126.23.230.230

Published: 2015

Journal Articles

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Xiong Ni, MD, Qingxiao Song, MD, Ruishu Deng, MD PhD, Hua Jin, BS, Kaniel M. Cassady, BS, Mingfeng Zhang, PhD, Stephen J. Forman, MD, Paul J. Martin, MD, Jianmin Wang, MD PhD, Defu Zeng, MD

Blood (2015) 126 (23): 1882.

https://doi.org/10.1182/blood.V126.23.1882.1882

Published: 2015

Journal Articles

Intestinal Epithelial HIF-1 Plays a Protective Role in Gut Graft Versus Host Disease

Rena Feinman, PhD, Iriana Colorado, MSc, Jenny Zilberberg, PhD, Anita Sreedhar, BA, Eugenia Dziopa, Leah Dziopa, Zheng Yang, Robert Korngold, PhD

Blood (2014) 124 (21): 539.

https://doi.org/10.1182/blood.V124.21.539.539

Published: 2014

Journal Articles

IL-22 Is an Intestinal Stem Cell Growth Factor, and IL-22 Administration in Vivo Reduces Morbidity and Mortality in Murine GvHD

Caroline A Lindemans, MD PhD, Anna Mertelsmann, Margaret Helen O'Connor, MS,BA, Jarrod A Dudakov, PhD, Robert Jenq, MD, Enrico Velardi, PhD, Lauren F. Young, BS, Odette M Smith, Gillian Lawrence, Natalie Luo, Juliet Ivanov, G Hua, PhD, Maria L Martin, Chen Liu, MD, PhD, Richard Kolesnick, MD, Marcel Van Den Brink, MD PhD, Alan M Hanash, MD PhD

Blood (2014) 124 (21): 651.

https://doi.org/10.1182/blood.V124.21.651.651

Published: 2014

Journal Articles

Eriguchi Y, Takashima S, Oka H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood . 2012;120(1): 223-231 .

Blood (2014) 124 (7): 1201.

https://doi.org/10.1182/blood-2014-07-586628

Published: 2014

Journal Articles

Paneth cells in gut GVHD: a Panglossian perspective

John Koreth

Blood (2013) 122 (8): 1336–1337.

https://doi.org/10.1182/blood-2013-06-509646

Published: 2013

Journal Articles

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality

John E. Levine, Elisabeth Huber, Suntrea T. G. Hammer, Andrew C. Harris, Joel K. Greenson, Thomas M. Braun, James L. M. Ferrara, Ernst Holler

Blood (2013) 122 (8): 1505–1509.

https://doi.org/10.1182/blood-2013-02-485813

Published: 2013

Includes: Supplemental data

Journal Articles

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Rie Kuroda, MD, Katsuaki Sato, MD, PhD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Kazuhito Naka, PhD, Makoto Naito, MD. PhD, Yoichiro Iwakura, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4669.

https://doi.org/10.1182/blood.V120.21.4669.4669

Published: 2012

Journal Articles

Intestinal Microbiota: From Inflammatory Bowel Disease to Bone Marrow Transplantation

Ernst Holler, PhD, Peter Oefner, Karin Landfried, MD, Josef Koestler, Elisabeth Huber, MD, Katrin Peter, Julia Ammer, MD, Gerhard Rogler, Marina Kreutz, Rainer Spang, Thomas Hehlgans, Matthias Edinger, Daniel Wolff, Andre Gessner, Reinhard Andreesen

Blood (2012) 120 (21): SCI-50.

https://doi.org/10.1182/blood.V120.21.SCI-50.SCI-50

Published: 2012

Journal Articles

Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins

Yoshihiro Eriguchi, Shuichiro Takashima, Hideyo Oka, Sonoko Shimoji, Kiminori Nakamura, Hidetaka Uryu, Shinji Shimoda, Hiromi Iwasaki, Nobuyuki Shimono, Tokiyoshi Ayabe, Koichi Akashi, Takanori Teshima

Blood (2012) 120 (1): 223–231.

https://doi.org/10.1182/blood-2011-12-401166

Published: 2012

Journal Articles

Host-Derived IL-22 Limits Graft Versus Host Disease and Protects the Intestinal Stem Cell Niche

Alan M. Hanash, MD, PhD, Jarrod A Dudakov, PhD, Guoqiang Hua, PhD, Lauren F. Young, BS, Maggie O'connor, Robert R Jenq, MD, Amanda M Holland, BS, Odette M Smith, BA, Chen Liu, PhD, Lynette Fouser, PhD, Richard Kolesnick, PhD, Bruce R. Blazar, MD, Marcel Van Den Brink, MD, PhD

Blood (2011) 118 (21): 309.

https://doi.org/10.1182/blood.V118.21.309.309

Published: 2011

Journal Articles

Both Tissue-Derived and Bone Marrow-Derived Host IL-17 Producing Cells Are Required for Preventing Acute Graft-Versus-Host Disease

Rie Kuroda, MD, Hideaki Maeba, MD, Katsuaki Sato, MD, PhD, Kazuhito Naka, PhD, Shintaro Mase, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Yoichiro Iwakura, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 2970.

https://doi.org/10.1182/blood.V118.21.2970.2970

Published: 2011

NARROW

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

T-Cell Derived Interferon Gamma Directly Targets Intestinal Epithelium to Induce Stem Cell Apoptosis in GI Gvhd

Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Inhibition of HIF Prolyl Hydroxylases Mitigate Gut Graft-Versus-Host Disease

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

High Mobility Group A1 Chromatin Remodeling Protein Regulates Self-Renewal, Niche Formation, and Regenerative Function in Adult Stem Cells through Wnt/β-Catenin Signaling

Intestinal Epithelial HIF-2 Is Protective in Gut Graft-Versus-Host-Disease

R-spondin1 Promotes Paneth Cell Growth, Maintains Intestinal Microbial Ecology, and Ameliorates GvHD

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Intestinal Epithelial HIF-1 Plays a Protective Role in Gut Graft Versus Host Disease

IL-22 Is an Intestinal Stem Cell Growth Factor, and IL-22 Administration in Vivo Reduces Morbidity and Mortality in Murine GvHD

Eriguchi Y, Takashima S, Oka H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood . 2012;120(1): 223-231 .

Paneth cells in gut GVHD: a Panglossian perspective

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Intestinal Microbiota: From Inflammatory Bowel Disease to Bone Marrow Transplantation

Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins

Host-Derived IL-22 Limits Graft Versus Host Disease and Protects the Intestinal Stem Cell Niche

Both Tissue-Derived and Bone Marrow-Derived Host IL-17 Producing Cells Are Required for Preventing Acute Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only